Events

Rappel de IMX SYSTEM - GLYCATED HEMOGLOBIN REAGENT

Selon Health Canada (via FOI), ce/cet/cette rappel concerne un dispositif en/au/aux/à Canada qui a été fabriqué par ABBOTT LABORATORIES LIMITED. DIAGNOSTIC DIVISION.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    20429
  • Classe de risque de l'événement
    II
  • Date de mise en oeuvre de l'événement
    2000-02-28
  • Pays de l'événement
    Canada
  • Source de l'événement
    HC
  • Notes / Alertes
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notes supplémentaires dans les données
  • Cause
    Abbott received an increased number of complaints for the imx glycated hemoglobin assay for error messages of "****" and/or "<3.61% ghb".

Device

IMX SYSTEM - GLYCATED HEMOGLOBIN REAGENT
  • Modèle / numéro de série
    Model Catalog: 1A86-88 (Lot serial: 60277M300 60278M300.); Model Catalog: 1A86-88 (Lot serial: 60275M300 60276M300); Model Catalog: 1A86-88 (Lot serial: 59545M200 60274M300); Model Catalog: 1A86-88 (Lot serial: 58157M400 58332M200); Model Catalog: 1A86-88 (Lot serial: 57411M200 58079M100); Model Catalog: 1A86-88 (Lot serial: 56566M200 56568M200)
  • Description du dispositif
    IMX GLYCATED HEMOGLOBIN
  • Manufacturer
    ABBOTT LABORATORIES LIMITED. DIAGNOSTIC DIVISION

Manufacturer

ABBOTT LABORATORIES LIMITED. DIAGNOSTIC DIVISION
  • Adresse du fabricant
    MISSISSAUGA
  • Société-mère du fabricant (2017)
    Abbott Laboratories
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    HC